StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)

Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –

Utah Medical Products pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Utah Medical Products's pe ratio was 22.3× on Nov 11, 2026, against 14.2× a year earlier. Over the last 5 years it ranged from 13.0× to 25.9×, with a median of 18.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202622.3×+8.1
2025Dec 31, 202514.1×+0.7
2024Dec 31, 202413.5×−4.7
2023Dec 29, 202318.2×−4.7
2022Dec 30, 202222.9×−3.0
2021Dec 31, 202125.9×−0.7
2020Dec 31, 202026.6×−2.7
2019Dec 31, 201929.3×+4.7
2018Dec 31, 201824.7×–

More Utah Medical Products figures

See a number that looks wrong?